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Objective. Assess the prevalence of abnormal glucose metabolism among Hispanic parents of children with acanthosis nigricans
(AN).Methods.Hispanicfamilies(n = 258)wereevaluatedformetabolicandanthropometricparametersincludingfastingglucose
levels and AN status. Results. Mothers with AN+ children had IFG (17.3%) and 4% had glucose levels ≥126mg/dL (P = 0.028)
compared to 7.1% and 1.8% of mothers with AN− children, respectively. Mothers of AN+ children also had greater odds of
having impaired fasting glucose levels (OR: 3.917, 95% CI: 1.475–10.404; P<0.004) but this was not the case for fathers (OR:
1.125, 95% CI: 0.489–2.586; P = 0.781). Mothers of AN+ children were also more likely to be AN+ (OR: 5.76, 95% CI: 2.98–11.13,
P<0.001). Screening discovered glucose levels >126mg/dL in 9% of fathers with AN+ children. Conclusions. Hispanic mothers
of AN+ children are at higher risk of carbohydrate metabolism abnormalities. AN in children can be a marker for prevention and
delay programs aimed at identifying adults at risk for diabetes.
1.Introduction
The emerging epidemic of obesity has been accompanied
by an increase in the prevalence of T2D in adolescents and
adults. With increasing evidence that childhood obesity pre-
cedes insulin resistance and abnormal glucose metabolism
and that the risk of diabetes has a strong genetic component
[1–3], there is a need to apply screening strategies that
identify children, their siblings, and parents at increased risk
for T2D and CVD [4].
Random screening is not eﬀective for identifying peo-
ple at risk for T2D. However, simple indicators, such as
acanthosis nigricans (AN), have been recommended by
American Diabetes Association (ADA) as one of the markers
to identify those at risk for T2D [5]. Acanthosis nigricans,
thickening and hyperpigmentation of the skin usually on
the neck and intertriginous areas, is frequently associated
with obesity, hyperinsulinemia [6, 7], and subsequent risk of
T2D [8, 9]. In a study of AN prevalence, 7.1% of unselected
1,412 children were AN positive [10]. The condition was
present in 0.5% of white non-Hispanics, (n = 440), 5.5%
of Hispanics (n = 343), and 13.3% of blacks (n = 601).
In a more recent report, nearly 40% of Native American
teenagers aged 10 to 19 years had acanthosis nigricans [6].2 ISRN Endocrinology
Between males and females, AN was equally distributed and
more common in obese children. Acanthosis nigricans has
also been reported to be familial in some cases [2] and is well
known to be associated with hyperandrogenism, polycystic
ovary syndrome (PCOS), and cancer [11–13].
Because diabetes can be prevented or delayed [14, 15],
it is imperative to identify those individuals at risk. This
is highlighted by data showing that as many as 70% of
pre-diabetic people will ultimately develop diabetes. The
process begins with metabolic dysfunction of which AN is a
marker [2, 7]. Over three to ﬁve years, approximately 25%
of pre-diabetic patients are likely to develop diabetes [16]
which carries a high risk of developing heart disease and
stroke[17].Further,identiﬁcationofundiagnoseddiabetesis
important because interventions to control fuel metabolism
can prevent or delay microvascular complications [18,
19].
Since many adults are reluctant or unable to fully par-
ticipate in health care, they may be unaware of developing
problems or deny the possibility that they are at risk.
An avenue to reach these persons may well be through
identiﬁcation of risk factors in their children. In the present
study, overweight/obese, AN-positive Mexican-American
children were selected as the basis for examining their
parents for abnormal glucose metabolism. Our hypothesis
was that the presence of AN in children would be associated
with abnormal fasting glucose metabolism in their parents.
Our ﬁndings demonstrate that the mothers of AN-positive
children were much more likely to be at risk for T2D than
mothers of children without AN. This observation suggests
that identiﬁcation of children that present with AN provides
additional opportunities for the detection and prevention of
T2D and CVD in Hispanic families.
2.MaterialsandMethods
2.1. Study Groups. In the present study, overweight/obese,
AN-positive Mexican-American children were selected as
the basis for examining their parents for abnormal glucose
metabolism. They were identiﬁed as at risk to develop type
2 diabetes at school screenings or referred by primary care
providers to a community-based family-focused preventive
program that aimed to change eating and physical activity
practices among these children and their families. Data
from 258 Hispanic families with overweight children were
evaluated for the relationship between the presence of AN in
children and the presence of glucose and lipid metabolism
abnormalities in their parents. Families with at least one
child at risk for T2D were invited to participate in the study.
ADA guidelines were used to identify AN-positive and AN-
negative children [5]. Children had a mean age of 11.1 years,
and approximately three fourths (72.3%) were US born.
Overall, adults were obese (BMI 30–32) and had a mean age
of 36.9 years; most of them were foreign born. Both children
(n = 446) and parents (n = 343, 229 mothers and 114
fathers) were assessed for risk factors for diabetes and CVD.
A b n o r m a lg l u c o s ei sd e ﬁ n e da sa n yg l u c o s e≥100mg/dL or
prior diagnosis of T2D. The abnormal glucose group was
further broken down into the familiar subsets of impaired
fasting glucose (IFG 100–125mg/dL), glucose ≥126mg/dL,
and known diabetes.
2.2. Anthropometric Measurements and Physical Exam.
Weight (lbs) and height (in) were converted to metric
units to calculate body mass index (BMI, kg/m2). Waist
circumference (cm) was measured with the participant in
a reclining position with the tape at the umbilicus and
measuring the circumference at the end of the participant’s
exhalation. Hip circumference was measured at the largest
circumference over the buttocks. Average blood pressure
(BP)wasobtained fromtwomeasurementsonthe rightarm.
Acanthosis nigricans (AN) was assessed by examination of
the neck [6, 7].
2.3. Laboratory Studies. All serum constituents were mea-
sured by methods and procedures of Quest Diagnostics
and included triglycerides (TG), total cholesterol (TC),
high-density lipoprotein cholesterol (HDL-C), low-density
lipoprotein cholesterol (LDL-C), glucose, insulin, and
homocysteine. C-reactive protein (CRP) and leptin were
determined using immunoassay kits (Biomerica, Newport,
CA, USA, and Biovendor, Brno, Czech Republic). Insulin
resistance (homeostasis assessment model for insulin resis-
tance (HOMA-IR)) was calculated as [glucose in mmol/L ×
insulin in µ units/22.5].
2.4. Statistical Analyses. All hypothesis tests were two-tailed,
and statistical signiﬁcance was assessed at the 0.05 level
using SPSS software. Student’s t-test was used to compare
means, and if data deviated signiﬁcantly from normality,
log-trans-formationsornonparametricmethods(theMann-
Whitney U test) were used. Arithmetic means were reported
for clarity. Chi-square was used to determine odds ratios and
conﬁdence intervals.
2.5. Human Subjects Investigation. Approval by the
UNTHSC and Cook Children’s Hospital IRB’s was obtained
prior to study.
3. Results
The distribution of parents with normal glucose, impaired
fasting glucose, glucose ≥126mg/dL, or known T2D was
mapped against the child’s AN status (Table 1). Divi-
sion by gender indicated that diﬀerences were signiﬁcant
among mothers (P<0.028) while the fathers dis-
played no signiﬁcant diﬀerence (P<0.531) although
screening indicated undiagnosed diabetes in 9% of the
fathers with AN-positive children. As illustrated (Table 2),
a mother with an AN-positive child had 5.759 greater
odds of being AN-positive and 3.917 greater odds of
having impaired fasting glucose. Over two-thirds (n =
123, 71.5%) of mothers of AN-positive children were AN
positive (Table 3) but only 30.4% (n = 17) of mothers
of AN-negative children were AN positive (P<0.001).ISRN Endocrinology 3











≥126 n (%) T2D n (%) P value∗ Total abnormal
n (%)
Mothers
n = 229 AN– 51 (91.1%) 4 (7.1%) 1 (1.8%) 0 (0%) 0.028 5 (8.9%)
AN + 125 (72.3%) 30 (17.3%) 7 (4.0%) 11 (6.4%) 48 (27.7%)
Fathers
n = 114 AN– 25 (67.6%) 11 (29.7%) 1 (2.7%) 0 (0%) 0.531 12 (32.4%)
AN + 50 (64.9%) 19 (24.7%) 7 (9.1%) 1 (1.3%) 27 (35.1%)
∗Chi-square.
Table 2: Odds ratio for abnormal glucose and acanthosis nigricans
in mothers and fathers with AN-positive and AN-negative children.
Parent Odds ratio (95% CI) P value
Abnormal glucose
Mothers 3.917 (1.475, 10.404) 0.004∗
Fathers 1.125 (0.489, 2.586) 0.781∗
Acanthosis nigricans
Mothers 5.759 (2.980, 11.129) 0.001∗
Fathers 1.971 (0.886, 4.386) 0.094∗
∗Chi-square.
Table 3: Frequencies and percentages of mothers and fathers with
acanthosis nigricans by AN-positive and AN-negative children.
Child’s AN status Parent AN− Parent AN+
Mothers
Child AN– 39 (69.6%) 17 (30.4%)
Child AN+ 49 (28.5%) 123 (71.5%)∗∗
Fathers
Child AN– 22 (59.5%) 15 (40.5%)
Child AN+ 32 (42.7%) 43 (57.3%)∗∗∗
Chi-square. ∗∗P<0.0001; ∗∗∗P<0.111.
Findings for fathers of AN-positive children followed the
same trend but were not signiﬁcant at P<0.05.
To explore additional diﬀerences between mothers of
AN-positive and AN-negative children, anthropomorphic
and serum parameters were compared (Table 4). Diastolic
blood pressure (DBP) was signiﬁcantly higher in mothers
of AN+ children (P<0.037) and BMI showed borderline
signiﬁcance (P = 0.060). Waist and waist/hip ratio (W/H)
were also higher in mothers of AN-positive children. Evalua-
tion of metabolic parameters showed higher levels of glucose
(P<0.036), TG (P<0.035), CRP (P<0.010), and leptin
(P<0.098) and lower HDL-C (P<0.029) in mothers of
AN-positive children. In contrast, fathers of AN-positive and
AN-negative children showed fewer signiﬁcant diﬀerences
(Table 5) though their BMI and waist and waist/hip ratio
(W/H) were higher among fathers of AN-positive children
(P<0.083) as was CRP (P<0.056). This unexpected
ﬁnding is likely due to the relatively small sample size. A
commonality between mothers and fathers of AN-positive
children was low HDL-C (P<0.035).
4. Discussion
Mexican-American elementary school children with and
without AN were selected to determine if their parents had
increased risk for diabetes and CVD. The study sought to
explore the hypothesis that AN could be a useful marker for
undiagnosedT2Dormetabolicabnormalitiesamongparents
of overweight children with AN. The ﬁndings suggest that
mothers of AN-positive children are likely to have abnormal-
itiesoffuelmetabolismcomparedtomothersofAN-negative
children. With respect to fathers, the number of participants
was perhaps too low to power this analysis. However, a
marker diﬀering the parents, based on oﬀspring AN status,
was the observation that the fathers of AN-positive children
were more likely to have blood glucose levels ≥126mg/dL
(Table 1). The study suggests that screening children for
AN is an eﬀective strategy for identifying adults with pre-
diabetes. We suggest that including children in screening
programs will be beneﬁcial for improving the quality of
diabetes prevention and delay initiatives, by identifying at-
risk persons.
Anumberofstudieshavepointedtoclusteringofchronic
diseases in families [2, 3, 20, 21]. Williams et al. [22] using
only family histories of CHD obtained from a questionnaire
distributed to high school students focused on a subset
comprising 14% of the general population. Surprisingly,
within that group, 72% of all persons with early CHD
(men < 55 years, women < 65 years) and 48% with CHD
at all ages were identiﬁed. This demonstrated that focused
screening programs can lead to identiﬁcation of a substantial
percentage (>50%) of the general population at risk for
CVD. Our studies suggest that the identiﬁcation of AN-
positive children can serve as a sentinel marker to identify
nuclear families at increased risk for T2D and consequently
for CVD.
Study limitations relate to the relative small sample size
and local nature of the study. Based on a sample size of4 ISRN Endocrinology
Table 4: Anthropomorphic and serum parameters of mothers with AN-negative and AN-positive children.
AN negative child (n = 56) AN positive child (n = 173)
Mean SE Mean SE P∗
Anthropomorphic parameters
Age 37.4 1.0 35.9 0.4
Weight (kg) 75.6 2.4 80.5 1.4 0.091
Height (m) 1.57 0.01 1.57 0.01
BMI 30.5 0.9 32.6 0.5 0.060
Waist (cm) 93.3 1.8 96.9 1.2
Hip size (cm) 109.8 1.7 112.4 1.1
Waist hip ratio 0.85 0.01 0.86 0.01
Blood Pressure
Systolic BP 115.3 2.3 119.1 1.4
Diastolic BP 67.8 1.4 71.0 0.7 0.037
Serum Parameters
Carbohydrate
Glucose 92.3 3.4 96.7 2.0 0.036
Insulin 8.5 0.8 9.1 0.5
HOMA 2.00 0.20 2.28 0.14
Lipid
TG 118.7 7.2 139.8 5.2 0.035
TC 184.6 4.3 182.0 2.4
LDL-C 109.6 3.7 106.6 2.1
HDL-C 51.2 1.6 47.4 0.8 0.029
TC/HDL-C 3.8 0.1 4.0 0.1
LDL-C/HDL-C 2.3 0.1 2.4 0.1
Other
Homocysteine 5.2 0.2 5.7 0.1 0.010
CRP (mg/L) 4.9 0.9 5.1 0.5
Leptin (mg/L) 28.4 2.4 33.5 1.6 0.098
∗Student’s t-test. All P values at P ≤ 0.10 listed.
229 mothers and 114 fathers, our study had approximately
8 0 %p o w e rt od e t e c ta no d d sr a t i oo f3 . 4o rg r e a t e rf o r
abnormal glucose among mothers with AN+ children and
3.2 or greater among fathers. Nonsigniﬁcant estimates could
have reached signiﬁcance with a larger sample size. However,
our study supports the hypothesis that the presence of AN
in a child is associated with abnormal glucose metabolism in
their mothers.
5. Conclusion
In addition to supporting the hypothesis that the presence
of AN in a child is associated with abnormal glucose
metabolism in their mothers, our work extends [23]a n d
validates another approach to developing focused screening
programs. Speciﬁcally, we showed that a physical marker
of risk present in children, AN, can be used to identify
adult relatives with or at risk for diabetes. Many adults
are reluctant or unable to fully participate in health care.
They may be unaware of developing problems or deny
the possibility that they are at risk. An avenue to reach
these persons may well be through identiﬁcation of risk
factors in their children. We suggest using the AN-positive
status of oﬀspring as selection criteria to screen families and
recommend interventions for prevention or management of
diabetes.ISRN Endocrinology 5
Table 5: Anthropomorphic and serum parameters of fathers with AN-negative and AN-positive children.
AN-negative child (n = 37) AN-positive child (n = 77)
Mean SE Mean SE P∗
Anthropomorphic parameters
Age 39.9 0.9 38.6 0.7
Weight (kg) 87.6 2.4 90.2 1.7
Height (m) 1.70 0.01 1.69 0.01
BMI 30.3 0.6 31.4 0.5
Waist (cm) 98.7 1.5 100.5 1.2
Hip size (cm) 105.3 1.1 104.8 0.9
Waist hip ratio 0.94 0.01 0.96 0.01 0.083
Blood pressure
Systolic BP 124.6 2.0 127.7 2.2
Diastolic BP 74.9 1.4 76.0 1.5
Serum parameters
Carbohydrate
Glucose 99.8 3.8 110.7 5.4
Insulin 8.2 1.0 9.2 0.9
HOMA 2.01 0.25 2.54 0.25
Lipid
TG 198.4 22.9 203.2 18.4
TC 209.9 9.0 202.3 4.8
LDL-C 126.3 8.1 121.6 3.9
HDL-C 43.9 1.8 40.1 0.9 0.035
TC/HDL-C 5.1 0.3 5.2 0.2
LDL-C/HDL-C 3.0 0.2 3.1 0.1
Other
Homocysteine 7.6 0.4 7.9 0.4
CRP (mg/L) 1.8 0.2 2.8 0.4 0.056
Leptin (mg/L) 11.3 1.5 10.0 0.9
∗Student’s t-test. All P values at P ≤ 0.10 listed.
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